Skip to main content
. 2022 Apr 14;9:856930. doi: 10.3389/fcvm.2022.856930

Table 2.

Lesion characteristics grouped according to outcomes during follow-up.

No. lesions
(n = 101)
No DoCE
(n = 87)
DoCE
(n = 14)
P -value
Vessels treated, n (%) 0.80
Left anterior descending 49 (49) 45 (49) 6 (43)
Left circumflex 23 (24) 19 (22) 4 (29)
Right coronary artery 27 (27) 23 (26) 4 (29)
Lesion types, n (%) 0.96
A 25 (25) 21 (24) 4 (29)
B1 41 (41) 35 (40) 6 (43)
B2 30 (30) 26 (30) 4 (29)
C 5 (5) 5 (2.8) 0 (0)
ISR, n (%) 8 (8) 6 (6.9) 2 (14) 0.34
Bifurcation lesions, n (%) 16 (16) 13 (15) 3 (21) 0.54
Aorto-ostial lesions, n (%) 0 (0.0) 0 (0) 0 (0) -
CTO, n (%) 3 (3) 3 (3.4) 0 (0) -
Degree of calcification, n (%) 0.92
None 45 (38.3) 39 (45) 6 (43)
Mild-to-moderate 51 (50) 44 (51) 7 (50)
Severe 5 (5) 4 (4.6) 1 (7.1)
Initial TIMI flow, n (%) 0.28
0 30 (30) 27 (31) 3 (21)
1 2 (2) 1 (1.1) 1 (7.1)
2 5 (5) 5 (5.7) 0 (0.0)
3 64 (63) 54 (62) 10 (71)
Final TIMI flow, n (%) -
2 2 (2.0) 2 (2.3) 0 (0.0)
3 99 (98) 85 (98) 14 (100)
No. of Mg-BRS per lesions, n (%) 1.2 ± 0.4 1.72 ± 0.38 1.21 ± 0.41 0.35
Mean device diameter (mm ± SD) 3.25 ± 0.25 3.25 ± 0.25 3.21 ± 0.25 0.30
Mean device length (mm ± SD) 22.1 ± 3.3 22.2 ± 3.3 21.7 ± 3.5 0.29
Deployment pressure (mm ± SD) 13.7 ± 2.5 13.5 ± 2.5 14.6 ± 2.2 0.07
Hybrid lesion treatment, n (%) 28 (8) 24 (28) 4 (20) 0.94
Pre-dilatation, n (%) 101 (100.0) 87 (100.0) 14 (100.0) -
Pre-dilatation device, n (%) 0.35
SC-balloon 10 (10) 10 (12) 0 (0.0)
NC- balloon 91 (90) 77 (89) 14 (100)
Post-dilatation, n (%) 98 (97) 84 (97) 14 (100) 1
Post-dilatation device, n (%) 0.20
SC- balloon 5 (5.1) 5 (6) 0 (0.0)
NC- balloon 41 (42) 37 (44) 4 (29)
Super-NC balloon 52 (53) 42 (50) 10 (71)
Maximal mean postdilatation pressure (atm ± SD) 24.2 ± 7.3 24.0 ± 7.1 25.4 ± 8.2 0.27
Fenestration of side branch, n (%) 11 (11) 11 (10.2) 0 (0.0) -
Intravascular imaging guidance, n (%) 8 (7) 8 (9.2) 0 (0.0) 0.6

Data are mean (standard deviation) or number (percentage), as appropriate.

CTO, chronic total occlusion; DoCE, device-oriented composite endpoint; ISR, in-stent restenosis; Mg-BRS, Magnesium bioresorbable scaffolds; NC, non-compliant balloon; No., Number; SC, semi-compliant balloon; TIMI, Thrombolysis in Myocardial Infarction.

P-values were based on student's t-tests, Mann-Whitney U- tests, or Chi-square tests, as appropriate.